Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Johnson & Johnson Innovation, LLC has announced 12 new alliances with life science companies and research institutions to explore early-stage innovation in a broad range of therapeutic areas and across pharmaceuticals, medical device, and...

Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company have announced the resubmission of a new drug application (NDA) for the investigational sodium glucose co-transporter-2 (SGLT2) inhibitor empagliflozin for the treatment of adults...

Janssen Pharmaceuticals, Inc. has entered into an exclusive license agreement with Vertex Pharmaceuticals for the worldwide development, manufacturing, and commercialization of VX-787, a medicine in Phase II development for the treatment of...

For its first "Meet Novartis Management" investor day, Novartis gathered more than 20 of its top executives, drawn from the leadership of its Pharmaceuticals, Alcon, and Sandoz Divisions, and the Novartis Institutes for BioMedical Research (NIBR)...

Pfizer Inc. and Cellectis, a French company specializing in immunotherapy, have entered into a global strategic collaboration to develop Chimeric Antigen Receptor T-cell (CAR-T) immunotherapies in the field of oncology directed at select...

The US Food and Drug Administration has posted a Warning Letter dated, June 16, 2014, for Apotex Pharmachem India based on the agency's inspection from January 27 through January 31, 2014 of the company's pharmaceutical manufacturing...

Affymax, Inc. and Takeda Pharmaceutical Company Limited (Takeda) will terminate their product collaboration and license agreement for Omontys (peginesatide), a drug to treat anemia due to chronic kidney disease in adult patients on dialysis,...